Literature DB >> 24366895

Conflicts at the heart of the FRAX tool.

Teppo L N Järvinen, Jarkko Jokihaara, Pierre Guy, Pablo Alonso-Coello, Gary S Collins, Karl Michaëlsson, Harri Sievänen.   

Abstract

Mesh：

Year:  2013        PMID： 24366895      PMCID： PMC3928201          DOI： 10.1503/cmaj.121874

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Shifting the focus in fracture prevention from osteoporosis to falls.

Authors:  Teppo L N Järvinen; Harri Sievänen; Karim M Khan; Ari Heinonen; Pekka Kannus
Journal:  BMJ       Date:  2008-01-19

2.  Is drug research trustworthy? The pharmaceutical industry funnels money to prominent scientists who are doing research that affects its products--and nobody can stop it.

Authors:  Charles Seife
Journal:  Sci Am       Date:  2012-12       Impact factor: 2.142

3.  Fracture risk assessment: state of the art, methodologically unsound, or poorly reported?

Authors:  Gary S Collins; Karl Michaëlsson
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

4.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

5.  Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines.

Authors:  Meghan G Donaldson; Peggy M Cawthon; Li-Yung Lui; John T Schousboe; Kristine E Ensrud; Brent C Taylor; Jane A Cauley; Teresa A Hillier; Dennis M Black; Doug C Bauer; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

Review 6.  Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review.

Authors:  Katrine Hass Rubin; Teresa Friis-Holmberg; Anne Pernille Hermann; Bo Abrahamsen; Kim Brixen
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

7.  Incidence of hip fracture in Romania and the development of a Romanian FRAX model.

Authors:  Daniel Grigorie; Alina Sucaliuc; Helena Johansson; John A Kanis; Eugene McCloskey
Journal:  Calcif Tissue Int       Date:  2013-01-19       Impact factor: 4.333

Review 8.  Interpretation and use of FRAX in clinical practice.

Authors:  J A Kanis; D Hans; C Cooper; S Baim; J P Bilezikian; N Binkley; J A Cauley; J E Compston; B Dawson-Hughes; G El-Hajj Fuleihan; H Johansson; W D Leslie; E M Lewiecki; M Luckey; A Oden; S E Papapoulos; C Poiana; R Rizzoli; D A Wahl; E V McCloskey
Journal:  Osteoporos Int       Date:  2011-07-21       Impact factor: 4.507
  8 in total
  12 in total

Review 1.  Artificial intelligence, osteoporosis and fragility fractures.

Authors:  Uran Ferizi; Stephen Honig; Gregory Chang
Journal:  Curr Opin Rheumatol       Date:  2019-07       Impact factor: 5.006

2.  Novel algorithm generating strategy to identify high fracture risk population using a hybrid intervention threshold.

Authors:  Chung-Yuan Hsu; Chih-Hsing Wu; Shan-Fu Yu; Yu-Jih Su; Wen-Chan Chiu; Ying-Chou Chen; Han-Ming Lai; Jia-Feng Chen; Chi-Hua Ko; Jung-Fu Chen; Tien-Tsai Cheng
Journal:  J Bone Miner Metab       Date:  2019-10-03       Impact factor: 2.626

Review 3.  A brief history of FRAX.

Authors:  John A Kanis; Helena Johansson; Nicholas C Harvey; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2018-10-31       Impact factor: 2.617

4.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.

Authors:  G S Collins; J B Reitsma; D G Altman; K G M Moons
Journal:  Br J Cancer       Date:  2015-01-06       Impact factor: 7.640

Review 5.  Osteoporosis: the emperor has no clothes.

Authors:  T L N Järvinen; K Michaëlsson; P Aspenberg; H Sievänen
Journal:  J Intern Med       Date:  2015-06       Impact factor: 8.989

6.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.

Authors:  Gary S Collins; Johannes B Reitsma; Douglas G Altman; Karel G M Moons
Journal:  BMC Med       Date:  2015-01-06       Impact factor: 8.775

7.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group.

Authors:  Gary S Collins; Johannes B Reitsma; Douglas G Altman; Karel G M Moons
Journal:  Circulation       Date:  2015-01-05       Impact factor: 29.690

8.  Clarifying WHO's position on the FRAX® tool for fracture prediction.

Authors:  Nathan Ford; Susan L Norris; Suzanne R Hill
Journal:  Bull World Health Organ       Date:  2016-12-01       Impact factor: 9.408

9.  The role of carboxy-terminal cross-linking telopeptide of type I collagen, dual x-ray absorptiometry bone strain and Romberg test in a new osteoporotic fracture risk evaluation: A proposal from an observational study.

Authors:  Fabio M Ulivieri; Luca P Piodi; Enzo Grossi; Luca Rinaudo; Carmelo Messina; Anna P Tassi; Marcello Filopanti; Anna Tirelli; Francesco Sardanelli
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

10.  Prediction of femoral strength using 3D finite element models reconstructed from DXA images: validation against experiments.

Authors:  Lorenzo Grassi; Sami P Väänänen; Matti Ristinmaa; Jukka S Jurvelin; Hanna Isaksson
Journal:  Biomech Model Mechanobiol       Date:  2016-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.